AOD Health
AOD Health
Episode 4: Dr Noa Krawczyk, PhD on the opioid use disorder treatment gap in the US
Episode 4: Dr Noa Krawczyk, PhD on the opioid use disorder treatment gap in the US
Episode 4: Dr Noa Krawczyk, PhD on the opioid use disorder treatment gap in the US
Tuesday 29th August 2023
Dr. Noa Krawczyk examines the opioid treatment gap in the U.S., discussing findings and potential policy changes on 'Behind the Evidence'.
29 minutes
Inspiring
Informative
Empowering
Thought-provoking
Hopeful
About this podcast
Author:
AOD Health
Overview:
Categories:
Innovative Treatments & Recovery Paths
Sobriety Toolkit
Nutritional Pathways to Recovery
Navigating Intimate Relationships
Links:
Visit site
Episodes:
6 (View all)
Do you want to link to this podcast?
Get the buttons here!Bridging the Opioid Treatment Divide: Insights from Dr. Noa Krawczyk
Episode Overview
- Dr. Krawczyk discusses the motivations behind her study and the iterative process of measurement
- The research reveals a substantial gap between the estimated number of people with opioid use disorder and those receiving treatment
- Dr. Krawczyk emphasizes the need to rethink the approach to medication treatments and the importance of minimizing disruption to patients' lives
- She discusses potential policy changes and highlights the upcoming conference organized by the National Coalition to Liberate Methadone
We need to rethink how we're offering these medications. Are they just offering a treatment program that was designed based on a conceptual framework of what treatment should look like? Or do we want to think about what people who are using opioids actually need and want and would be willing to engage in?
What if the gap between those needing treatment for opioid use disorder and those actually receiving it could be narrowed? This episode of 'Behind the Evidence' brings you a compelling conversation with Dr. Noa Krawczyk, PhD, an assistant professor at NYU School of Medicine. She dives into her latest research published in The International Journal of Drug Policy, examining the opioid treatment gap in the U.S. from 2010 to 2019. Dr.
Krawczyk's study reveals a persistent and troubling gap between the number of individuals diagnosed with opioid use disorder and those who receive proper treatment. Over the decade-long study, there was only a slight decrease in this disparity, prompting urgent questions about our current approach to medication treatments. Dr. Krawczyk suggests that minimizing disruptions in patients' lives could be key to improving treatment rates. Hosts Honora L. Englander, MD, and Marc R.
Larochelle, MD, guide the discussion with their expert insights, making complex data accessible and engaging. They explore various databases and adjustment methods used in the study, shedding light on why this gap exists and what can be done to address it. The episode also touches on potential policy changes and highlights the upcoming National Coalition to Liberate Methadone conference. It's a thought-provoking listen for anyone interested in understanding the challenges and opportunities in tackling the opioid crisis.
Whether you're a healthcare professional, someone affected by addiction, or just curious about the state of opioid treatment in the U.S., this episode offers valuable perspectives and actionable insights.